Comera Investor Presentation Deck

Leveraging SQore to Build Our Own SQ Pipeline Development focus is utilizing SQore platform to reformulate existing, commercially proven IV biologics to SQ forms, then out-licensing to partners after IND filing Multiple asset opportunities Short-term development Low capital intensity • Lower risk vs. novel program ● ● • Near-term return ● SQore™ ● TM Comera LIFE SCIENCES PIPELINE Limited investment focused on reformulating existing biologics from IV to SQ Low development cost, goal to get to IND and then out- license 2-3 years to monetization 18

View entire presentation